Stock ALTME TME PHARMA N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart TME Pharma N.V.

Equities

ALTME

NL0015000YE1

Real-time Euronext Paris
Other stock markets
 04:41:36 2024-06-05 am EDT 		5-day change 1st Jan Change
0.245 EUR +1.03% Intraday chart for TME Pharma N.V. -1.80% +6.52%
Apr. 25 TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 23 TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
TME PHARMA N.V.
Other Biotechnology & Medical Research
+1.03%-1.80%+6.52%-82.35%-99.67% 7.5M
Neutral
Neutral
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ALTME Stock
  4. Charts TME Pharma N.V.
  5. Comparison Chart